• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

川崎病凝血谱的变化及其与临床分类、静脉注射免疫球蛋白反应性和冠状动脉受累的关系。

The changes of coagulation profiles in Kawasaki disease and its associations with clinical classification, intravenous immunoglobulin responsiveness and coronary artery involvement.

机构信息

Department of Paediatrics, The First Affiliated Hospital of Anhui Medical University, No. 218 Ji-Xi Road, Hefei, 230022, Anhui Province, People's Republic of China.

出版信息

Clin Exp Med. 2024 Aug 6;24(1):177. doi: 10.1007/s10238-024-01430-z.

DOI:10.1007/s10238-024-01430-z
PMID:39105936
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11303485/
Abstract

Coagulation disorders are common in Kawasaki disease (KD). The main objectives of the present study were to probe the associations of coagulation profiles with clinical classification, IVIG responsiveness, coronary artery abnormalities (CAAs) in the acute episode of KD. A total of 313 KD children were recruited and divided into six subgroups, including complete KD (n = 217), incomplete KD (n = 96), IVIG-responsive KD (n = 293), IVIG-nonresponsive KD (n = 20), coronary artery noninvolvement KD (n = 284) and coronary artery involvement KD (n = 29). Blood samples were collected within 24-h pre-IVIG therapy and 48-h post-IVIG therapy. Coagulation profiles, conventional inflammatory mediators and blood cell counts were detected. Echocardiography was performed during the period from 2- to 14-day post-IVIG infusion. In addition, 315 sex- and age-matched healthy children were enrolled as the controls. (1) Before IVIG therapy, coagulation disorders were more prone to appear in KD patients than in healthy controls, and could be overcome by IVIG therapy. FIB and DD significantly increased in the acute phase of KD, whereas reduced to normal levels after IVIG therapy. (2) PT and APTT were significantly longer in patients with complete KD when compared with their incomplete counterparts after IVIG therapy. (3) The larger δDD, δFDP and the smaller δPT, δINR predicted IVIG nonresponsiveness. (4) The higher δDD and δFDP correlated with a higher risk for CAAs (DD: r = -0.72, FDP: r = -0.54). Coagulation disorders are correlated with complete phenotype, IVIG nonresponsiveness and CAA occurrence in the acute episode of KD, and can be rectified by synergistic effects of IVIG and aspirin.

摘要

凝血障碍在川崎病(KD)中很常见。本研究的主要目的是探讨凝血谱与临床分类、IVIG 反应性、KD 急性期冠状动脉异常(CAA)的关系。共招募 313 例 KD 患儿,分为 6 个亚组,包括完全 KD(n=217)、不完全 KD(n=96)、IVIG 反应性 KD(n=293)、IVIG 非反应性 KD(n=20)、无冠状动脉受累 KD(n=284)和冠状动脉受累 KD(n=29)。在 IVIG 治疗前 24 小时内和 IVIG 治疗后 48 小时内采集血样。检测凝血谱、常规炎症介质和血细胞计数。在 IVIG 输注后 2-14 天进行超声心动图检查。此外,还招募了 315 名性别和年龄匹配的健康儿童作为对照组。(1)在 IVIG 治疗前,KD 患儿比健康对照更易出现凝血障碍,且 IVIG 治疗可纠正凝血障碍。KD 急性期 FIB 和 DD 显著增加,IVIG 治疗后降至正常水平。(2)IVIG 治疗后,完全 KD 患者的 PT 和 APTT 明显长于不完全 KD 患者。(3)较大的 δDD、δFDP 和较小的 δPT、δINR 预测 IVIG 无反应性。(4)较高的 δDD 和 δFDP 与 CAA 发生的风险增加相关(DD:r=-0.72,FDP:r=-0.54)。在 KD 急性期,凝血障碍与完全表型、IVIG 无反应性和 CAA 发生有关,且可通过 IVIG 和阿司匹林的协同作用得到纠正。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61e2/11303485/685d049d1431/10238_2024_1430_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61e2/11303485/632f87412dc6/10238_2024_1430_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61e2/11303485/685d049d1431/10238_2024_1430_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61e2/11303485/632f87412dc6/10238_2024_1430_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61e2/11303485/685d049d1431/10238_2024_1430_Fig2_HTML.jpg

相似文献

1
The changes of coagulation profiles in Kawasaki disease and its associations with clinical classification, intravenous immunoglobulin responsiveness and coronary artery involvement.川崎病凝血谱的变化及其与临床分类、静脉注射免疫球蛋白反应性和冠状动脉受累的关系。
Clin Exp Med. 2024 Aug 6;24(1):177. doi: 10.1007/s10238-024-01430-z.
2
Interleukin-6 is prone to be a candidate biomarker for predicting incomplete and IVIG nonresponsive Kawasaki disease rather than coronary artery aneurysm.白细胞介素-6 易于成为预测川崎病不完全反应和免疫球蛋白静脉注射无反应的候选生物标志物,而非冠状动脉瘤。
Clin Exp Med. 2019 May;19(2):173-181. doi: 10.1007/s10238-018-00544-5. Epub 2019 Jan 8.
3
The time option of IVIG treatment is associated with therapeutic responsiveness and coronary artery abnormalities but not with clinical classification in the acute episode of Kawasaki disease.静脉注射免疫球蛋白治疗的时间选择与治疗反应性和冠状动脉异常有关,但与川崎病急性期的临床分类无关。
Pediatr Rheumatol Online J. 2019 Jul 31;17(1):53. doi: 10.1186/s12969-019-0352-3.
4
TNF-α is superior to conventional inflammatory mediators in forecasting IVIG nonresponse and coronary arteritis in Chinese children with Kawasaki disease.TNF-α 在预测中国川崎病儿童 IVIG 无反应和冠状动脉炎方面优于传统炎症介质。
Clin Chim Acta. 2017 Aug;471:76-80. doi: 10.1016/j.cca.2017.05.019. Epub 2017 May 16.
5
The role of serum lipid in predicting coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease: a cohort study.血清脂质在预测川崎病冠状动脉病变和静脉注射免疫球蛋白抵抗中的作用:一项队列研究。
J Int Med Res. 2024 May;52(5):3000605241252115. doi: 10.1177/03000605241252115.
6
Clinical implications of procalcitonin in Kawasaki disease: a useful candidate for differentiating from sepsis and evaluating IVIG responsiveness.降钙素原在川崎病中的临床意义:鉴别败血症和评估 IVIG 反应的有用候选指标。
Clin Exp Med. 2021 Nov;21(4):633-643. doi: 10.1007/s10238-021-00709-9. Epub 2021 Apr 11.
7
Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.急性川崎病的治疗:重新审视阿司匹林在发热阶段的作用。
Pediatrics. 2004 Dec;114(6):e689-93. doi: 10.1542/peds.2004-1037. Epub 2004 Nov 15.
8
Persistent endothelial damage after intravenous immunoglobulin therapy in Kawasaki disease.川崎病静脉注射免疫球蛋白治疗后持续存在的内皮损伤。
Int Arch Allergy Immunol. 2014;165(2):111-8. doi: 10.1159/000368402. Epub 2014 Nov 15.
9
Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD CAA prevention (KD-CAAP) trial protocol.多中心、随机、开放标签、盲终点评估的皮质类固醇加静脉注射免疫球蛋白(IVIG)和阿司匹林与 IVIG 和阿司匹林预防川崎病(KD)冠状动脉瘤(CAA)的试验:KD CAA 预防(KD-CAAP)试验方案。
Trials. 2023 Jan 26;24(1):60. doi: 10.1186/s13063-022-07051-9.
10
Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.土耳其儿童川崎病:单中心经验,重点关注静脉注射免疫球蛋白抵抗和巨大冠状动脉瘤
Turk J Pediatr. 2019;61(5):648-656. doi: 10.24953/turkjped.2019.05.002.

引用本文的文献

1
Treatment with intravenous immunoglobulin modulates coagulation- and complement-related pathways in COVID-19 patients.静脉注射免疫球蛋白治疗可调节新冠肺炎患者的凝血和补体相关途径。
Front Immunol. 2025 Jul 31;16:1623309. doi: 10.3389/fimmu.2025.1623309. eCollection 2025.

本文引用的文献

1
Tocilizumab in multisystem inflammatory syndrome in children (MIS-C)-summarized experiences.托珠单抗治疗儿童多系统炎症综合征(MIS-C)——总结经验
J Eur Acad Dermatol Venereol. 2023 Apr;37(4):e443-e446. doi: 10.1111/jdv.18784. Epub 2022 Dec 3.
2
The clinical implications of serum ferritin in Kawasaki disease: a helpful biomarker for evaluating therapeutic responsiveness, coronary artery involvement and the tendency of macrophage activation syndrome.血清铁蛋白在川崎病中的临床意义:一种有助于评估治疗反应性、冠状动脉受累情况及巨噬细胞活化综合征倾向的生物标志物。
Arch Med Sci. 2021 Dec 8;18(1):267-274. doi: 10.5114/aoms/144293. eCollection 2022.
3
American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 3.
美国风湿病学会儿童 COVID-19 相关 SARS-CoV-2 与儿童多系统炎症综合征及过度炎症的临床指导:第 3 版
Arthritis Rheumatol. 2022 Apr;74(4):e1-e20. doi: 10.1002/art.42062. Epub 2022 Feb 3.
4
Plasma fibrinogen, D-dimer, and fibrin degradation product as biomarkers of rheumatoid arthritis.血浆纤维蛋白原、D-二聚体和纤维蛋白降解产物作为类风湿关节炎的生物标志物。
Sci Rep. 2021 Aug 19;11(1):16903. doi: 10.1038/s41598-021-96349-w.
5
Multisystem inflammatory syndrome in children (MIS-C) and the prothrombotic state: Coagulation profiles and rotational thromboelastometry in a MIS-C cohort.儿童多系统炎症综合征(MIS-C)与血栓前状态:MIS-C 队列中的凝血特征和旋转血栓弹性描记术。
J Thromb Haemost. 2021 Jul;19(7):1764-1770. doi: 10.1111/jth.15340. Epub 2021 Jun 4.
6
Clinical implications of procalcitonin in Kawasaki disease: a useful candidate for differentiating from sepsis and evaluating IVIG responsiveness.降钙素原在川崎病中的临床意义:鉴别败血症和评估 IVIG 反应的有用候选指标。
Clin Exp Med. 2021 Nov;21(4):633-643. doi: 10.1007/s10238-021-00709-9. Epub 2021 Apr 11.
7
Predictive value of coagulation profiles for both initial and repeated immunoglobulin resistance in Kawasaki disease: A prospective cohort study.预测川崎病初次和重复免疫球蛋白治疗抵抗的凝血谱价值:一项前瞻性队列研究。
Pediatr Allergy Immunol. 2021 Aug;32(6):1349-1359. doi: 10.1111/pai.13495. Epub 2021 Mar 20.
8
SARS-COV-2-associated coagulopathy and thromboembolism prophylaxis in children: A single-center observational study.儿童中与 SARS-CoV-2 相关的凝血障碍和血栓栓塞预防:一项单中心观察性研究。
J Thromb Haemost. 2021 Feb;19(2):522-530. doi: 10.1111/jth.15216. Epub 2020 Dec 23.
9
American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 2.美国风湿病学会儿童与 SARS-CoV-2 相关的多系统炎症综合征和儿科 COVID-19 中过度炎症的临床指导:第 2 版。
Arthritis Rheumatol. 2021 Apr;73(4):e13-e29. doi: 10.1002/art.41616. Epub 2021 Feb 15.
10
Phase II Open Label Study of Anakinra in Intravenous Immunoglobulin-Resistant Kawasaki Disease.静脉注射免疫球蛋白耐药性川崎病阿那白滞素的 II 期开放标签研究。
Arthritis Rheumatol. 2021 Jan;73(1):151-161. doi: 10.1002/art.41481. Epub 2020 Nov 17.